BerlinskiA, PenningtonD. Effect of interval between actuations of albuterol hydrofluoralkane pressurized metered dose inhalers on their aerosol characteristics. Respir Care, 2017; 62(9):1123–1130.
2.
MandelbergA, ChenE, NoviskiN, PrielIE. Nebulized wet treatment in emergency department—is it essential? Comparison with large spacer device for metered-dose inhaler. Chest, 1997; 112(6):1501–1505.
3.
IdrisAH, McDermottMF, RaucciJC, MorrabelA, McGorrayS, HendelesL. Emergency department treatment of severe asthma: metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Chest, 1993; 103(3):665–672.
4.
SchultzA, Le SouëfTJ, VenterA, ZhangG, DevadasonSG, Le SouëfPN. Aerosol inhalation from spacers and valved holding chambers requires few tidal breaths for children. Pediatrics, 2010; 126(6):e1493–e1498.
5.
GeorgeM, JoshiSV, ConcepcionE, LeeH. Paradoxical bronchospasm from benzalkonium chloride (BAC) preservative in albuterol nebulizer solution in a patient with acute severe asthma: a case report and review of the literature. Respir Med Case Rep, 2017; 21:39–41.
6.
PollockM, SinhaIP, HartlingL, RoweBH, SchreiberS, FernandesRM. Inhaled short-acting bronchodilators for managing emergency childhood asthma: an overview of reviews. Allergy, 2017; 72(2):183–200.
7.
AmiravI, LuderAS, HalamishA, MarzukC, DaitzchmanM, NewhouseMT. Computerized dead-space volume measurement of face masks applied to simulated faces. Respir Care, 2015; 60(9):1247–1251.
8.
van AalderenWM, GriggJ, GuilbertTW, RocheN, IsraelE, MartinRJ, et al. Small-particle inhaled corticosteroid as first-line or step-up controller therapy in childhood asthma. J Allergy Clin Immunol Pract, 2015; 3(5):721–731.
9.
KrishnanJA, MartinMA, LohffC, MosnaimGS, Margellos-AnastH, DeLisaJA, et al. Design of a pragmatic trial in minority children presenting to the emergency department with uncontrolled asthma: the CHICAGO plan. Contemp Clin Trials, 2017; 57:10–22.
